{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-170512","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.745926+00:00","generated_at":"2026-05-17T22:43:10.550531+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ResMed Q4 revenue up 10% to $1.35B, EPS $2.58; dividend raised 13% to $0.60","bullets":["Q4 revenue $1.35B (+10% YoY, +9% CC); GAAP EPS $2.58 (+30%), non-GAAP EPS $2.55 (+23%).","Gross margin up 230bps to 60.8% GAAP; operating income $454.5M (+19%).","FY2025 revenue $5.15B (+10%); GAAP EPS $9.51 (+37%).","Dividend raised 13% to $0.60/share; payable Sept 18, record Aug 14; ex-div Aug 13."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-170512","json":"https://secwatch.observer/filing/0001193125-25-170512.json","markdown":"https://secwatch.observer/filing/0001193125-25-170512.md","text":"https://secwatch.observer/filing/0001193125-25-170512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312525170512/0001193125-25-170512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312525170512/d926247d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:43:10.550531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}